Striim Releases Validata to Ensure Data Accuracy and Deliver Trusted AI GlobeNewswire December 10, 2025 PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Striim, a global leader in real-time data intelligence for enterprise AI, today announced Validata, a new product for data validation and reconciliation at scale. Enterprise AI and agentic systems demand trustworthy […]
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire December 10, 2025 NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire December 10, 2025 LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the
Deadline Alert: StubHub Holdings, Inc. (STUB) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire December 10, 2025 LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming January 23, 2026 deadline to file a lead plaintiff motion in
WelcomeVille Investment Association Under Reginald Pembroke Launches an Advanced EdTech Collaborative Learning Network WelcomeVille Investment Association, led by Reginald Pembroke, launches a next-generation EdTech platform designed to deliver structured peer learning and real-time digital collaboration. GlobeNewswire December 10, 2025 Chicago, IL, Dec. 10, 2025 (GLOBE NEWSWIRE) — WelcomeVille Investment Association has introduced a major upgrade
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy GlobeNewswire December 10, 2025 Highly encouraging early data from the ongoing Phase 1b study evaluating investigational drug GNS561 with a MEK inhibitor (MEKi) in KRAS mutated cholangiocarcinoma (CCA), positioning this novel combination as a potential new therapeutic approach for difficult-to-treat cancers: No dose limiting toxicity reached
Fort Point Real Estate Partners Launches with Portfolio of 40 San Francisco Multifamily Properties New platform focused on long-term, responsible multifamily ownership in San Francisco assembles multi-building portfolio GlobeNewswire December 10, 2025 SAN FRANCISCO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Fort Point Real Estate Partners (“Fort Point”), a San Francisco-based real estate investment firm, today
DEADLINE ALERT for AVTR, SNPS, KMX, INSP: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions GlobeNewswire December 10, 2025 BENSALEM, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire December 10, 2025 NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit
Foster City, California, Dec. 10, 2025 (GLOBE NEWSWIRE) — Bayside Builders Group, a licensed, bonded, and insured home remodeling contractor with more than 25 years of experience, announced the completion of its 100th high-efficiency kitchen remodel in Foster City. This milestone highlights the company's commitment to helping homeowners lower energy costs, modernize their homes, and